These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7723247)

  • 1. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes.
    Pereira BJ; Snodgrass BR; Hogan PJ; King AJ
    Kidney Int; 1995 Feb; 47(2):603-10. PubMed ID: 7723247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
    Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
    Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
    Sundaram S; Barrett TW; Meyer KB; Perrella C; Neto MC; King AJ; Pereira BJ
    J Am Soc Nephrol; 1996 Oct; 7(10):2183-91. PubMed ID: 8915979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate.
    Jaber BL; Gonski JA; Cendoroglo M; Balakrishnan VS; Razeghi P; Dinarello CA; Pereira BJ
    Blood Purif; 1998; 16(4):210-9. PubMed ID: 9736790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention of cytokine-inducing substances inside high-flux dialyzers.
    Lufft V; Mahiout A; Shaldon S; Koch KM; Schindler R
    Blood Purif; 1996; 14(1):26-34. PubMed ID: 8718562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine production during in vitro hemodialysis with new and formaldehyde- or renalin-reprocessed cellulose dialyzers.
    Pereira BJ; Snodgrass B; Barber G; Perella C; Chopra S; King AJ
    J Am Soc Nephrol; 1995 Oct; 6(4):1304-8. PubMed ID: 8589302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood.
    Linnenweber S; Lonnemann G
    ASAIO J; 2000; 46(4):444-7. PubMed ID: 10926143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrafiltration and endotoxin removal from dialysis fluids.
    Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
    Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production by human peripheral blood mononuclear cells stimulated by a Pseudomonas aeruginosa culture filtrate: role of plasma and polymyxin B.
    Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Pereira BJ
    Int J Artif Organs; 1996 May; 19(5):276-83. PubMed ID: 8791147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
    Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria.
    Lonnemann G; Behme TC; Lenzner B; Floege J; Schulze M; Colton CK; Koch KM; Shaldon S
    Kidney Int; 1992 Jul; 42(1):61-8. PubMed ID: 1635355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
    Kumano K; Yokota S; Nanbu M; Sakai T
    Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrogen transfer across high- and low-flux hemodialysis membranes.
    Weber V; Linsberger I; Rossmanith E; Weber C; Falkenhagen D
    Artif Organs; 2004 Feb; 28(2):210-7. PubMed ID: 14961961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins (LPS).
    Laude-Sharp M; Caroff M; Simard L; Pusineri C; Kazatchkine MD; Haeffner-Cavaillon N
    Kidney Int; 1990 Dec; 38(6):1089-94. PubMed ID: 2127434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Net ultrafiltration may not eliminate backfiltration during hemodialysis with highly permeable membranes.
    Leypoldt JK; Schmidt B; Gurland HJ
    Artif Organs; 1991 Jun; 15(3):164-70. PubMed ID: 1907821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profiles during clinical high-flux dialysis: no evidence for cytokine generation by circulating monocytes.
    Grooteman MP; Nubé MJ; Daha MR; Van Limbeek J; van Deuren M; Schoorl M; Bet PM; Van Houte AJ
    J Am Soc Nephrol; 1997 Nov; 8(11):1745-54. PubMed ID: 9355078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis.
    Lonnemann G; Sereni L; Lemke HD; Tetta C
    Artif Organs; 2001 Dec; 25(12):951-60. PubMed ID: 11843762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dialysate and biocompatibility in hemodialysis].
    Berland Y
    Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced cytokine induction and removal of complement products with synthetic hemodialysis membranes.
    Schindler R; Ertl T; Beck W; Lepenies J; Boenisch O; Oppermann M; Kaspar E; Frei U
    Blood Purif; 2006; 24(2):203-11. PubMed ID: 16373999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis.
    Schindler R; Lonnemann G; Schäffer J; Shaldon S; Koch KM; Krautzig S
    Nephron; 1994; 68(2):229-33. PubMed ID: 7830861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.